zantac 360

Generic: famotidine

Labeler: navajo manufacturing company inc.
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name zantac 360
Generic Name famotidine
Labeler navajo manufacturing company inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

famotidine 20 mg/1

Manufacturer
Navajo Manufacturing Company Inc.

Identifiers & Regulatory

Product NDC 67751-214
Product ID 67751-214_16276432-35b8-25ca-e063-6394a90a0115
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA206531
Listing Expiration 2026-12-31
Marketing Start 2022-08-01

Pharmacologic Class

Established (EPC)
histamine-2 receptor antagonist [epc]
Mechanism of Action
histamine h2 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 67751214
Hyphenated Format 67751-214

Supplemental Identifiers

RxCUI
310273 2609246
UNII
5QZO15J2Z8
NUI
N0000000151 N0000175784

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zantac 360 (source: ndc)
Generic Name famotidine (source: ndc)
Application Number ANDA206531 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/1
source: ndc
Packaging
  • 1 BLISTER PACK in 1 CARTON (67751-214-01) / 1 TABLET, FILM COATED in 1 BLISTER PACK
  • 2 BLISTER PACK in 1 CARTON (67751-214-02) / 1 TABLET, FILM COATED in 1 BLISTER PACK
source: ndc

Packages (2)

Ingredients (1)

famotidine (20 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "16276432-35b8-25ca-e063-6394a90a0115", "openfda": {"nui": ["N0000000151", "N0000175784"], "unii": ["5QZO15J2Z8"], "rxcui": ["310273", "2609246"], "spl_set_id": ["e328c59c-baed-0e4e-e053-2995a90ab85c"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Navajo Manufacturing Company Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (67751-214-01)  / 1 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "67751-214-01", "marketing_start_date": "20220801"}, {"sample": false, "description": "2 BLISTER PACK in 1 CARTON (67751-214-02)  / 1 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "67751-214-02", "marketing_start_date": "20220801"}], "brand_name": "Zantac 360", "product_id": "67751-214_16276432-35b8-25ca-e063-6394a90a0115", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "67751-214", "generic_name": "Famotidine", "labeler_name": "Navajo Manufacturing Company Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Zantac 360", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "20 mg/1"}], "application_number": "ANDA206531", "marketing_category": "ANDA", "marketing_start_date": "20220801", "listing_expiration_date": "20261231"}